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PEMENCILAN DAN PENCIRIAN AKTINOMISET MARIN UNTUK AKTIVITI 
ANTI-JANGKITAN PADA Pseudomonas aeruginosa PA14 
 
ABSTRAK 
Persekitaran marin berfungsi sebagai takungan luas metabolit sekunder berguna 
dan pada masa yang sama, agen anti-jangkitan baru dikehendaki untuk memerangi 
bakteria patogen tahan antibiotik. Kajian ini dijalankan untuk menyaring agen anti-
jangkitan daripada persekitaran yang mampu mengatasi jangkitan Pseudomonas 
aeruginosa melalui anti-virulen atau meningkatkan aktiviti imuniti perumah. Mendapan 
tanah laut dipungut dari Pulau Songsong, Yan, Kedah, Malaysia dan sebanyak 18 
aktinomiset dengan morfologi yang berbeza telah berjaya dipencilkan. Metabolit 
sekunder dari semua pencilan telah diekstrak dengan menggunakan kaedah 
pengekstrakan pepejal-cecair dan telah disaring untuk aktiviti anti-jangkitan 
menggunakan model jangkitan Caenorhabditis elegans. Hanya ekstrak dari pencilan A5 
menunjukkan pertambahan jangka hayat yang ketara daripada perumah. Oleh itu, ia 
telah digunakan untuk pencirian dan saringan lanjut. Pencilan A5 menunjukkan 99.7% 
persamaan jujukan molekular kepada Streptomyces sundarbansensis MS1/7 dan telah 
dinamakan sebagai Streptomyces sundarbansensis CCB-PSK207 kerana perbezaan 
morfologi yang diperhatikan di bawah kondisi percambahan yang sama. Ia boleh 
menahan sehingga 10% (w / v) kepekatan NaCl dan menunjukkan pertumbuhan tertinggi 
(merujuk kepada berat kering sel) pada pH7 selepas sepuluh hari percambahan 
berbanding dengan pH4, pH5, pH6, pH8, pH 9 dan pH10. Ekstrak metanol A5 
seterusnya dikelaskan lagi menggunakan kaedah pengekstrakan cecair-cecair. Pecahan 
xiv 
 
n-heksana didapati mempamerkan hit yang terbaik dalam asai ketahanan. Asai tindak 
balas dos mendedahkan bahawa 400μg/mL adalah kepekatan yang terbaik dengan 
perubahan kadar ketahanan 69.65±4.50% berbanding cacing kawalan selepas 96 jam 
jangkitan PA14. Oleh itu, semua asai penyaringan telah diteruskan dengan kepekatan 
tersebut. Pecahan ini tidak menunjukkan kesan ke atas pertumbuhan kinetik PA14 dan ia 
juga tidak menyebabkan sekatan pemakanan dalam perumah. Dalam asai visualisasi lys-
7, ekspresi GFP yang signifikan telah diperhatikan dalam cacing jangkitan PA14 yang 
menerima 400 μg/mL pecahan n-heksana. Intensiti GFP yang kuat telah dipamerkan di 
seluruh badan cacing yang mencadangkan bahawa ekspresi gen lys-7 dalam populasi 
cacing yang dijangkiti telah dipulihkan. Pecahan ini seterusnya diasingkan oleh kaedah 
kromatografi lapis tipis preparatif.  Tiga fraksi iaitu (A5HA, A5HB dan A5HC) telah 
diasingkan dan sekali lagi disaring untuk asai ketahanan. Fraksi A5HB menunjukkan hit 
yang terbaik dengan perubahan 71.43±4.67% kadar ketahanan berbanding cacing yang tidak 
dirawat. Sebatian fraksi telah dikenal pasti oleh analisis GC-MS dengan kehadiran 
beberapa metil ester asid lemak tepu dan bercabang. Kesimpulannya, fraksi 
mengandungi sebatian kompaun dengan keupayaan menyelamatkan C. elegans melalui 
aktiviti pengantara lys-7. 
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ISOLATION AND CHARACTERIZATION OF MARINE ACTINOMYCETES 
FOR ANTI-INFECTIVE ACTIVITY TOWARDS Pseudomonas aeruginosa PA14 
 
ABSTRACT 
 Marine environment serve as reservoir of vast useful secondary metabolites and 
at the same time, new anti-infective agents are required to combat antibiotic resistant 
pathogenic bacteria.Therefore, this research was carried out to screen for anti-infective 
agents from the environment that are capable of overcoming Pseudomonas aeruginosa 
infection through anti-virulence or boosting of host immunity activities. Marine soil 
sediments were collected from Songsong Island, Yan, Kedah, Malaysia and a total of 18 
actinomycetes with different morphology were successfully isolated. Secondary 
metabolites from all isolates were extracted out using solid-liquid extraction method and 
were screened for anti-infective activity using Caenorhabditis elegans infection model. 
Only extract from isolate A5 showed significant life-span promotion of the host. Thus, it 
was used for further characterization and screening. Isolate A5 showed 99.7% molecular 
sequence similarity to Streptomyces sundarbansensis MS1/7 and was designated as 
Streptomyces sundarbansensis CCB-PSK207 due to morphological difference observed 
under the same culture condition. It can withstand up to 10% (w/v) NaCl concentration 
and it showed highest growth (referring to cell dry weight) at pH7 after ten days of 
cultivation compared to pH4, pH5, pH6, pH8, pH 9 and pH10. Methanolic extract A5 
was further partitioned by using liquid-liquid extraction method. n-hexane partition was 
found to exhibit the best hit in survival assay. Dose response assay revealed that 
xvi 
 
400µg/mL was the best concentration with survivability rate change of 69.65±4.50% as 
compared to controlled worms 96-hours post PA14 infection. Therefore, all screening 
assays were progressed using that concentration. The partition showed no effects on the 
kinetic growth of PA14 and it also did not cause dietary restriction in the host. In lys-7 
visualization assay, a significant GFP expression was observed in PA14-infected worm 
that received 400 µg/mL n-hexane partition treatment. Strong GFP intensity was 
exhibited all over the worm body which suggested that the expression of lys-7 gene in 
the infected worm population was restored. The partition was further isolated by 
preparative thin layer chromatography method. Three fractions (A5HA, A5HB and 
A5HC) were isolated and once again screened for survival assay. Fraction A5HB 
showed the best hit, with 71.43±4.67% survival rate change compared to the untreated 
worms. Compounds in the fraction were identified by GC-MS analysis with presence of 
several methyl esters of saturated and branched fatty acids. In conclusion, the fraction 
contains compounds with capability of rescuing C. elegans through lys-7 mediated 
activity. 
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CHAPTER 1 
1.0 Introduction 
 Pseudomonas aeruginosa is listed as the multi-drug resistant Gram-negative 
pathogen. Since it was first observed in 1850 and until now, it is still an infection which 
needed research and new development for treatment opportunity (Lister et al., 2009). 
Therefore, it is very worrying that we are running out of antibiotics option. In this 
situation, opportunity in developing methods to control and treat infection of P. 
aeruginosa is an important step. However, the development of other drugs will cause 
resistance among bacteria with encoded resistance gene. Therefore, a good choice of 
drug is the one not only will target the bacterial virulence factor but also will modulate 
the host defence. The selectivity of anti-infective in which only non-essential genes are 
being targeted for disruption impose a lower probability of resistance development 
(Mellbye and Schuster, 2011) and at the same time preserve cell viability of the host. 
 While the search of new therapeutic drugs from nature to combat the pathogen 
infection is continuously being carried out, researchers found that actinomycetes are 
popular among antibiotics and other drug producers which might be a potential 
therapeutic drug for pathogen infections. Marine actinomycetes are less popular as 
compared to terrestrial actinomycetes but their potentials are undeniable. Recently, 
marine environment is becoming a spotlight for novel drugs excavation because it is 
under-explored but rich in diversity of bacteria as most bacteria in the sea was found to 
help in degradation and cycle of organic matter (Lam, 2006). Studies have proven 
that actinomycetes isolated from the marine environment are capable to produce novel 
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secondary metabolites and have adapted to life in the sea. They also have different 
characteristics from those of the terrestrial group because of the different environmental 
conditions. So, it gives a run down that they might produce different types of bioactive 
compounds (Imada et al., 2007) making up an interest to study the marine actinomycetes 
as a new therapeutic method to combat P. aeruginosa infection. 
 In the development of new therapeutic drugs, most of studies will use animal or 
tissue culture for drug testing as they are close to human cellular and development 
systems. However, the use of animal for drug testing needs a lot of space, time 
consuming, high cost and most importantly considered against the animal ethics. On the 
other hand, the use of tissue culture is a tedious work, as maintaining the cells and 
keeping it free from contaminant is easier said than done. Therefore, application of 
Caenorhabditis elegans as host infection model is a better approach as compared to 
other conventional method. Nowadays, C. elegans has been widely used as it is very 
easy to be cultivated in the laboratory with a short life-cycle of about three days of 
cultivation (Riddle et al., 1997). Moreover, it complements both in vitro and in vivo 
mammalian models in toxicology due to its success in genetic manipulability, invariant 
and fully described developmental program and well-characterized genome (Leung et 
al., 2008). Besides, C. elegans also have clear ortholog with human genes (Shaye and 
Greenwald, 2011; Kaletta and Hengartner, 2006; Culetto and Satelle, 2000). Therefore, 
it makes C. elegans a close relative to the human system and the most suitable host for 
toxicology and drug testing upon all of its characters. 
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1.1 Problem statements 
 There is abundance of infectious cases reported to be related to P. aeruginosa. 
Antibiotics have been invented but drug resistance appear to be another problem when 
dealing with living organisms. This is the biggest problem faced by the global 
community that lead to this research. Therefore, this research was meant to look for 
another initiative to treat the infection by stimulating immunity of the host rather than 
killing the pathogen. 
 Many compounds have been discovered with abilities as anti-infective agents that 
were isolated from plants and even microorganisms. But only terrestrial microorganisms 
were mostly studied for that intention while marine microorganisms are being 
underexplored. Not much are known about the capabilities of marine microorganisms in 
producing useful therapeutic agents and this situation caused a loss to pharmaceutical 
industries. 
  
1.2       Scope of study 
 The study covers the scope of microbiology involving actinoycetes isolated from 
marine sediment. Besides, it also includes the study of natural products produced from 
the isolated actinomycetes. 
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1.3 Premises for research 
 The isolation, characterization and identification of the isolates were carried out at 
CR1 Lab in Centre for Chemical Biology (CCB) which is a collaboration research lab. 
Bioassays and all the screening process using C. elegans were carried out at Assay 
Department in the Institute of Pharmaceutical and Nutraceutical Malaysia (IPharm). All 
the chemical works were performed at the School of Chemical Sciences, USM. 
 
1.4  Objectives 
The objectives of the study were: 
i. To isolate actinomycetes from marine sediments  
ii. To determine extracts with potential anti infective activity towards infection of P. 
aeruginosa PA14 in C. elegans 
iii. To isolate and identify possible compounds with anti-infective activity by 
preparative TLC method and GC-MS analysis 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Pseudomonas aeruginosa: the common pathogen 
 P. aeruginosa is a Gram-negative rod shaped bacteria with the ability to anchor, 
colonize and spread infection to the host. Pseudomonal infection is easily detected with 
the presence of blue-green colourization during culture. The colourization was first 
observed by Sêdillot in 1850 on a surgical wound dressing (Lister et al., 2009).  P. 
aeruginosa can be found in almost everywhere because it is able to tolerate variety of 
physical conditions and able to survive with minimal nutritional requirements. Human 
atmosphere such as home humidifiers, swimming pools, whirlpools, hot tubs, soil and 
rhizosphere, vegetables and contact lens solution are among examples of this organism’s 
reservoir (Harris et al., 1984).  
 In the hospital, P. aeruginosa can be isolated from sinks, mops, respiratory 
therapy equipment and physiotherapy and hydrotherapy pools (Lister et al., 2009). 
Usually acquired from hospital or health care facility, P. aeruginosa infection was one 
of the most common pathogen involved in mostly reported nosocomial infection 
(Diekema et al., 1999) affecting almost 2 million patients and 9,000 death each year. As 
nosocomial infections occur during hospital stay, it caused prolonged stay, disability, 
and economic burden to the patients. Frequently prevalent infections are catheter-
associated urinary tract infection, surgical site infections and ventilator-associated 
pneumonia (Khan et al., 2017). Urinary tract infection is on the top list of nosocomial 
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infection with about 80% of infections are associated with the use of an indwelling 
bladder catheter (Mulcahy et al., 2014). Urinary infections are associated with less 
morbidity than other nosocomial infections, but can occasionally lead to bacteraemia 
and death (Mayon-White et al., 1988). Infection rates are higher among patients with 
increased susceptibility because of old age, underlying disease, or chemotherapy (Rafiee 
et al., 2016). Nosocomial surgical site infections are also frequently reported. The 
incidence varies from 0.5 to 15% depending on the type of operation and underlying 
patient status. The infection usually acquired during the operation itself, either from 
outside sources such as air, surgeons and medical appliances or from the inside of the 
patients such as the flora of the patient’s skin (Guggenbichler et al., 2011).  The 
ventilator associated pneumonia mostly takes place in the intensive care unit with 
reported incidence of 9% to 70% (Vincent, 2003). Approximately 8 to 28% of patients 
receiving prolonged mechanical ventilation (more than 48 hours) will develop 
ventilator-associated pneumonia (Cook and Kollef, 1998).  
 Despite all, P. aeruginosa is one of the common microbial florafound in human. 
About 2% of them colonize the skin, 6.6% colonize the throat, 3.3% colonize the nasal 
mucosa and 2.6 to 24% are found in fecal samples (Morrison and Wenzel, 1984). But, 
among patients who have records with trauma or a cleft in mucosal or cutaneous barriers 
by mechanical ventilation, tracheostomy, catheters, surgery, or severe burns, the 
colonization can exceed to 50% compared to a healthy human (Blanc et al., 1998; Erol 
et al., 2004; Valles et al., 2004). Disturbance of the normal microbial flora due to 
improper antimicrobial therapy event and patients with defective immune system have 
higher risks for P. aeruginosa infection (Morrison and Wenzel, 1984). 
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 Many virulence factors such as adhesins, proteases, phenazines, type III secretion 
system exotoxins (T3SS) (Pereira et al., 2014), exotoxin A, exoenzyme S and 
hemolysins (Delden and Iglewski, 1998) are secreted by a mechanism involving cell to 
cell signaling systems of P. aeruginosa that allow the bacteria to produce these factors in 
a coordinated manner upon cell density dependency. In the initial stage of infection, 
adhesins, such as lectins and motility features allow the bacteria to adhere to the host 
cells (Strateva and Mitov, 2011), while proteases degrade elastin which represents 28% 
of the lung tissue (Okumura et al., 2008). At the same time phenazines impair 
mitochondrial activity and the production of neutrophiles and macrophages. It also 
increases intracellular oxidative stress (Bradbury et al., 2010). On the other hand, T3SS 
exotoxin stimulates eukaryotic cells apoptosis and spreading of disease from the lung in 
pneumonia infection (Hauser, 2009). Exotoxin A causes clinical infections by catalyzing 
ADP-ribosylation and inactivation of elongation factor 2, causing inhibition of protein 
biosynthesis and later, cell death (Wick et al., 1990). It causes local tissue damage and 
bacterial infection (Woods and Iglewski, 1983). Another exotoxin known as exoenzyme 
S which functions like exoenzyme A, an ADP-ribosyl transferase, preferentially 
favoured GTP-binding proteins such as Ras (Iglewski et al., 1978). It leads to tissue 
destruction in lung infection and is responsible for bacterial invasion. Rhamnolipid and 
phospholipase C are two hemolysins produced by P. aeruginosa that work together to 
break down lecithin and lipids. Rhamnolipid has a structure like detergent, which 
solubilizes the phospholipids of lung surfactant, allowing easier access of phospholipase 
C to cleave the structure of lung surfactant leading to chronic and acute P. aeruginosa 
lung infection (Delden and Iglewski, 1998). 
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 Despite all the productions and secretions, the virulence factors are controlled by 
quorum sensing (QS) mechanism. In 2003, Smith and Iglewski proposed a model of P. 
aeruginosa quorum sensing mechanism. The model showed that during infection, 
quorum sensing molecule 30-C12-HSL is produced in high concentration thus 
stimulating host cell to secrete multiple inflammatory mediators. The induction of 
interleukin, IL-8 and other mediators trigger the migration of many different cell types 
to the site of infection. However, as P. aeruginosa are protected in biofilm, immune  cell 
such as neutrophils are unable to clear the infection and ultimately result in tissue 
destruction due to P. aeruginosa infection causing it hard to be treated. Many drugs have 
been invented to treat the infection of P. aeruginosa. Along with the developments of 
antibiotics, bacterial pathogens are also evolving, adapting to the antibiotic used and 
become resistant to it. 
 
2.2 Antibiotic resistance the global problem 
 Antibiotic resistance is the problem faced globally. Pathogens that are treated 
with particular antibiotic sometimes are not fully cleared. Few cells that carried resistant 
gene will remain and cause antibiotic resistance. They performed mechanisms such as 
efflux pumping that channel out antibiotics from the cell, making them more difficult to 
be treated and we are running out of treatment option. Besides, bacteria are able to pick 
up resistance gene from other bacteria by using three main strategies. First, they obtain a 
whole plasmid coded with one or more resistance gene from a donor cell. Second, virus 
also plays a main role by transferring genes from one bacterium to another through 
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injection. The injected genes that are stably incorporated will remain in the new 
bacterium. And third, they scavenge gene bearing bacteria and swipe it into their 
environment (Levy, 1998). Figure 2.1 shows a model of bacterial cell resistance 
mechanism. There are three pathways (a, b and c) involved in the mechanism. Firstly, a) 
the genes that are coded for efflux pump play the role to channel out antibiotic out of the 
cell. Second, b) the genes are coded for enzyme to degrade antibiotics and finally, c) the 
genes that help in the chemical alteration and inactivation of the drug are delivered to 
destroy the pathogen’s cell.  
 
Figure 2.1: Antibiotic resistance mechanism in bacteria (Levy, 1998) 
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  A national surveillance by using the Intensive Care Unit Surveillance Study 
database from ICU patients in USA showed that multidrug resistance of P. aeruginosa 
increased significantly, from 4% in 1993 to 14% in 2002 (Obritsch et al., 2004). For 
comparison, another ICU surveillance study evaluated from 1997 to 2002 and reported 
an increase in case report of multidrug-resistant strains from 13% to 21% (Livermore, 
2002). The number increase dramatically each year with multi-resistance to drugs 
(resistance to three and more drugs) such as lactams and aminoglycosides. 
 In Pseudomonas earuginosa, imported resistance mechanism and chromosomally 
encoded mechanism are the cause or arising multi-drug resistance phenotype. Imported 
resistance mechanism involved acquisition of resistance genes on mobile genetic 
elements such as plasmids. For chromosomally encoded mechanism, the three most 
studied chromosomal encoded resistance gene in P. aeruginosa are the AmpC 
cephalosporinase, the OprD outer membrane porin and the multidrug efflux pump. 
These encoded genes gave abilities that appoint Pseudomonas aeruginosa one of the 
greatest therapeutic challenge (Lister et al., 2009). AmpC is the chromosomally encoded 
enzyme that is found in most Gram-negative bacteria from family Enterobacteriaceae 
and also P. aeruginosa. This enzyme cause resistance as it is inducible by a number of 
β-lactams antibiotics such as cephalothin and most penicillins along with regulation of 
AmpR. Upon exposure to antibiotics, ampC is expressed, leading to hydrolization of 
lactone and amides (lactams) thus causing inactivation of the drug (Jacoby, 2009).  
 OprD is a transport protein that facilitate transportation of basic amino acids and 
β-lactam carbapenem, imipenem into the cells.  Resistance mechanism occur with the 
lost of function of OprD in which antibiotic could not be transported into the cell (Osch 
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et al., 1999). This might happen due to deletion of oprD causing frameshift mutation and 
generation of premature termination codon (Yoneyama and Nakae, 1993). Efflux pump 
is also a specific transportation method into the cell. A study on the multidrug efflux 
pump made up of three main components: the cytoplasmic membrane associated drug-
proton antiporter of the Resistance Nodulation-Division (RND) family, outer membrane 
factor (OMF) which is a channel-forming protein and the periplasmic membrane fusion 
protein (MFP) was carried out. There are about four RND-MFP-OMF type multidrug 
efflux pump of P. aeruginosa that have been described which are MexAB-OprM, 
MexCD-OprJ, MexEF-OprN and MexXY-OprM (Poole, 2001). Generally, these efflux 
pumps lead to resistance as they exported out the compounds from inside the cell to 
outside of the cell (Webber and Piddock, 2003). Therefore, drugs transported into the 
cell are also exported out.  
 Antibiotic resistance and antibiotic limitation have been an alarming problem 
that urged researchers to find more efforts in solving it. It initiatively make way to 
adoption of different new strategies such as anti-infective agents which not only combat 
the pathogen after infection but take care of the infection at the early stage. 
 
2.3 Anti-infective agents 
 Drugs.com website describe anti-infective agent as an agent with the ability to 
react upon infection. It may act by suppressing transmission of infection or by directly 
killing the infectious agent. Antibiotics, antifungals, antibacterials, antivirals and 
antiprotozoans are generally referred to as anti-infective agents. From other perspective, 
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anti-infective agent selectively acts by modulating the immunity of the host or by 
disrupting the virulence-mediated pathways without affecting microbial cell viability 
(Kong et al., 2014b). Therefore, in order to avoid global problems of antibiotic 
resistance, initiative of using anti-infective agent should be taken into account.  
 The awareness of antibiotic resistance problem had risen since early 1988 when 
resistance towards vancomycin was also reported. Shimmel and co-workers (1998) 
firstly suggested synthase as the key to combat antibiotic resistance. They suggested the 
use of aminoacyl tRNA synthase, a universal enzyme as target for new drugs discovery 
that able to inhibit pathogen infection but not the host cells counterpart.  They also 
demonstrate efficacy of the synthase inhibitor by using animal model in vivo. 
 One of the well-known anti-infective compounds is the anti-microbial peptide 
(AMP), the small molecular weight positively charged proteins with both hydrophobic 
and hydrophilic side. This characteristic enables it to be soluble in both aqueous and 
lipid membrane environment. It exhibits a broad spectrum antimicrobial activity against 
viruses, bacteria and fungi (Izadpanah and Gallo, 2005). This AMP plays a crucial role 
as effectors of innate immunity in most living organisms on skin and mucosal surfaces 
since 2.6 billion years ago (Gordon et al., 2005). Most AMPs are produced by the cells 
itself but the production of AMPs can be stimulated through vaccination or upon 
infection of specific cells by pathogen (Bahar and Ren, 2013). AMP have been reported 
to exhibit anti-infective properties in Staphylococcus epidermidis with no cytotoxic 
effect to the mammalian cells. Natural AMP showed that AMP target the lipid bilayer 
membrane of pathogen while synthetic AMP designed and enhanced to target diverse 
range of target even at a very low concentration (Agarwal et al., 2016).  
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 Instead of small peptide compounds, there are groups that go for  natural product 
screening for anti-infective option and more efforts in finding novel anti-infective agents 
were carried out because anti-infective screening of natural products from medicinal 
plant and microorganisms showed potential source of anti-infective agents. Medicinal 
plant extract from Mauritians flora exhibit anti-infective properties towards tested 
pathogens including P. aeruginosa with 57.1% susceptibility to the tested extract and 
100% susceptibility towards Bacillus subtilis (Rangasamy et al., 2007). Besides that, a 
whole organism infection model employed in anti-infective screening towards P. 
aeruginosa involving host treated with seed extract of Swietenia macrophylla from 
Malaysian environment also demonstrated a positive result with 59.5% of the host 
survived the infection of P. aeruginosa PA14 upon treatment of the mentioned extract 
(Dharmalingam et al., 2012).  In comparison, Rudrappa and Bais (2008) also 
demonstrated anti-infective screening of curcumin extract that save the host towards 
infection of P. aeruginosa PA01 by reduction of virulence factor expression of the 
pathogen. 
 Instead of natural product from plant, products from microorganisms were also 
screened for potential anti-infective activities. Marine bacteria Verrucosispora AB-18-
032 showed good inhibitory activity against MRSA (methicillin resistant Staphylococcus 
aureus) and VRSA (vancomycin resistant S. aureus) with discovery of abyssomicin C 
(Rahman et al., 2010). On the other hand, Streptomyces sp. isolated from marine sponge 
reported to exhibit anti-infective properties and also led to a very first discovery of 
valinomycin from the marine source (Pimentel-Elardo et al., 2010).  
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2.4 Caenorhabditis elegans as host infection model  
2.4.1 C. elegans biology 
 C. elegans host model system has been introduced by Sydney Brenner in 1965. 
C. elegans is a nematode species that can be found all over the world. They inhabit leaf 
litter and are saprophytic (Hope, 1999). It has a simple anatomy which plays a crucial 
role in the selection as a model organism (Brenner, 1974). It has been widely used as it 
is very easy to be cultivated in the laboratory and it has a short life-cycle of about 3 days 
of cultivation (Riddle et al., 1997). C. elegans goes through four larval stage (L1- L4), 
from hatching to adult. Incident of food depletion and pheromone influence at L2 stage 
will drive the larvae into an alternative juvenile stage called the “dauer” larvae which 
can live up to four months without food source (Golden and Riddle, 1982). Figure 2.2 
shows life cycle of C. elegans from eggs to adult and probability of juvenile arrested 
‘dauer’ stage.  
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Figure 2.2: Life cycle of C. elegans 
Image source: http://www.wormatlas.org/ver1/handbook/anatomyintro/anatomyintro. 
htm (accessed on November 18, 2015). 
 
Adult worm is about 1.5 mm in length and produced about 300-350 progeny per 
worm. The use of the worms as an potential host is comparable to the T4 phage by the 
number of progeny produced while the breeding method are comparable to the one in 
the plant (Riddle et al., 1997). C. elegans complements both in vitro and in vivo 
mammalian models in toxicology due to its success in genetic manipulability, invariant 
and fully described developmental program and well-characterized genome (Leung et 
16 
 
al., 2008). The invariant number of somatic cells in C. elegans allows a full track of 
every significant cell developmental changes such as the neuronal, hypodermal, muscle 
and digestive cells. The changes can be tracked starting from egg-fertilization until adult 
stage so that the fate of every cell is known (Sulston and Horvitz, 1977). C. elegans 
protein-coding genes presumed that about 38% of C. elegans gene have clear orthologs 
in human genome (Shaye and Greenwald, 2011) and 60-80% of human genes have 
ortholog in C. elegans genome (Kaletta and Hengartner, 2006). Culetto and Sattelle 
(2000) reported that about 40% of known genes that are related to human disease have 
orthologs in C. elegans genome. Therefore, it urges adoption of different strategies in 
order to seek new anti-infective therapeutic agents including practices by using the 
whole animal infection model such as Caenorhabditis elegans (Kirienko et al., 2013; 
Moy et al., 2006).   
 
2.4.2 C. elegans host-pathogen interaction 
 Mammalian innate immunity is far too complicate to be directly studied. 
Therefore, C. elegans is listed among the best candidate for host-pathogen interaction 
for innate immunity study. Earlier, Drosophila and mouse was also used to study effects 
of anti-microbial peptide on innate immunity of the host but then it revealed the 
complicated functional conservation of Toll signalling between insect and human 
(Poltorak et al., 1998). Therefore, C. elegans was used to get a clearer idea of the 
mammalian innate immunity studies. C. elegans also provide a genetically tractable 
mechanism of host defense (Kim, 2008).    
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 Besides, the ability of C. elegans that allows various pathogens to establish an 
effective infection allows assessment of bacterial pathogenesis with any pathogen of 
interest. Three modes of infections that are the intestinal infection, cuticle infection and 
infection of tail region that cause swelling response are suggested to elicit immune 
response of the host (Kim, 2008). This mode of infection allows various killing 
mechanism to be studied. Kong and co-workers (2014b), studied interaction between C. 
elegans and Staphylococcus aureus upon infection while Rudrappa and Bais (2008) used 
Pseudomonas aeruginosa PA01 as the pathogen. More pathogens were actually used 
such as Burkholderia pseudomallei (Eng and Nathan, 2015), Microbacterium 
nematophilum (Hodgkin et al., 2000) and Streptococcus pneumonia (Jansen et al., 
2002). 
 On the other hand, there are signalling pathways and genes that are homolog to 
humans system. The conserved pathway of immune signaling in C. elegans PMK-1 p38 
mitogen-activated protein kinase (MAPK) pathway is in relative position with 
mammalian apoptosis signal-regulating kinase 1(ASK1)-MAPK kinase 3/6 (MKK3/6)-
p38 MAPK pathway involved in innate immunity (Aballay et al., 2003). Another gene 
homolog to human is the tol-1 that homolog to Toll-like receptor (TLR) (Pujol et al., 
2001). Next gene involved is tir-1 that ortholog to human TIR (Transport Inhibitor 
Response) domain protein MyD88-5 whose responsible in primary responses in human 
(Mink et al., 2001). Therefore, TIR-1 is related to the function of ASK1-dependent 
PMK-1 p38 MAPK pathway during defense towards pathogen (Liberati et al., 2004). In 
AWC chemosensory neuron, TIR-1 was also reported to play role in neuronal 
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development as it is responsible in ASK1-dependent activation of a MAPK distinct to 
PMK-1 (Chuang and Bargmann, 2005).  
 Besides, the well-studied genetic of C. elegans has led to the study of gene 
expression of host upon pathogen infection. It suggested that infection of pathogen 
induced production of common classes of genes associated with lysozyme and C-type 
lectin domain-containing protein as defense mechanism of the host towards infection 
(Kim, 2008). Further microarray based study upon these genes were also carried out and 
a comparative analysis of these genes with genes regulated by the PMK-1 showed that 
about 15% of PMK-1-regulated genes are also induced by P. aeruginosa. This further 
proved that the PMK-1 pathway is related to C. elegans innate immune response upon 
pathogen infection (Troemel et al., 2006). 
 Moreover, the study of host-pathogen relation in C. elegans does not only 
involve the tissue on site of infection. This is because C. elegans are able to exhibit 
behavioral changes upon infection. Besides, physiological processes such as 
reproduction and growth are also related to defense mechanism towards pathogen (Kim, 
2008). 
 
2.4.3 C. elegans in drug discovery and screening 
  Among the earliest C. elegans research has started since 1900 when Maupas 
successfully identified C. elegans. Then in 1948, Dougherty and Calhoun proposed to 
use C. elegans in their genetic research. After that, Brenner took a first step in 1963 by 
obtaining C. elegans sample from Dougherty and started his molecular-genetic work in 
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collaboration with Sulston until the genetic sequence was completed in the year of 1997 
(Riddle et al., 1997).  Since then, C. elegans has been a famous manipulation tool and 
extensively used in drugs discovery, screening and evaluation as compared to the 
traditional cell drug screening method. 
 As compared to the traditional cell drug screening, the whole animal infection 
model of C. elegans allows an early and direct assessment of in vivo drug efficacy. At 
the same time, compounds that cause toxicity to the host and compounds with poor 
pharmacokinetic properties are eliminated. Besides, it allows identification of potential 
hits that selectively disrupt virulence pathways established by pathogens (Moy et al., 
2009). C. elegans infection model give opportunity to simultaneously identify 
compounds that not only target the bacterial virulence factor but also modulating the 
host defence (Kong et al., 2014b). Therefore, based on the concept, the selectivity of 
anti-infective in which only non-essential genes are targeted for disruption feasibly 
impose a lower probability of resistance development (Mellbye and Schuster, 2011) and 
at the same time preserve cell viability of the host. 
 Note that, C. elegans was not only used for anti-infective screening but a lot 
more was done. The first method of drug screening using C. elegans host infection 
model was carried out by Brenner in 1974 by incorporating the drug in the agar during 
screening. After that, this model organism was used in more drug screening practices 
such as in anti-aging research in 1977 by Klass who stated that this model allowed a 
consistent life-span to be measured with manipulation of food source and incubation 
temperature (Tissenbaum, 2015). This agar screening model was also used to model 
mammalian bacterial pathogenesis the P. aeruginosa PA14 (Tan et al., 1999). In 2012, 
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Dharmalingam and co-workers used the same C. elegans agar screening method to 
screen Swietenia macrophylla seed extract efficacy towards infection of P. aeruginosa 
PA14. However, this agar based method consumed large amount of compound and 
laborious. Therefore, it was improved to High Throughput Screening (HTS) with higher 
resolution and efficiency. 
 The first large scale of high throughput screening was reported on 2006 carried 
out by Kwok and colleagues. They use fully automated worm transfer using 
a Complex Object Parametric Analyzer and Sorter (COPAS™ BIOSORT, Union 
Biometrica) and semi-automated image acquisition to screen 14,100 small molecules 
and identified 308 bio-active compounds (Kwok et al., 2006).  Moy and co-workers 
(2006) are among the earlier group to perform liquid-based screening assay using C. 
elegans. They successfully screened 1,136 natural product extract and 6,000 synthetic 
compounds towards infection of Enterococcus fecalis and found that out of the number, 
16 compounds and 6 extracts improved survival of host upon pathogen infection. Next, 
anti-fungal of 1,266 compounds with known pharmaceutical activities were screened 
towards Candida albican-C. elegans infection model through HTS and 15 of the 
compounds showed positive result (Breger et al., 2007). In 2011, Zhou and co-workers 
screened 1,300 extracts for accessing bio-activity of the extracts towards infection of P. 
aeruginsa in C. elegans and they discovered 36 extracts that improve survival of the host 
upon infection. 
 As discussed above, it proved that C. elegans has been extensively used as the 
tool for drug discovery for about four decades and many of its innate immunity and 
microbial pathogenesis are well studied by using this model (Ewbank and Zugasti, 
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2011).  Therefore, this work has been carried out to study the main component produced 
by the actinomycetes that act as immune modulator of the host upon infection of P.  
aeruginosa.  
 
2.5 Introduction of actinomycetes 
 Bacteria which belong to the order Actinomycetales were informally called 
aerobic actinomycetes. Microorganisms of this order were originally classified as fungus 
as they possess the same characteristic, the true aerial hyphae. Later on, further studies 
were carried out on their cell wall component particularly the cell envelope lipid and  
peptidoglycan compositions. They are now classified as the true aerobic bacteria 
(McNeil and Brown, 1994). Actinomycetes are typically Gram-positive filamentous free 
living bacteria that are saprophytic. They grow slower than common bacteria which take 
up to three weeks to be seen clearly on the agar plate particularly on media rich in 
protein. At the early stage, actinomycetes colonies are very hard to be differentiated 
among common bacteria colonies. But longer incubation time make it easier to be seen 
as a chalky deposit which often appear around the colony. Sometimes it forms a 
concentric ring around it (Haines, 1931).  
 Actinomycetes colonies are usually found in the form of white powdery, leathery, 
pinpoint and creamy (Gebreyohannes et al., 2013; Valli et al., 2012). Most 
actinomycetes produce coloured pigment in their colonies as their secondary metabolites 
(Demain, 1998). Actinomycetes have a special recognition based on their smell of earth 
which actually comes from the substance secreted by actinomycetes called geosmin. 
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This event caused the smell of soil during growth of actinomycetes (Gerber and 
Lechevalier, 1965).  
 Actinomycetes also produce dry spores like most fungi (Kalakoutski and Agre, 
1976) which are airborne contaminants in most working places such as agriculture land 
and waste composting site (Lacey, 1989). The variety and abundance of actinomycetes 
in any specific environment is mostly depends on the type of cultivation, geographical 
location, soil and organic matter among other factors (Arifuzzaman et al., 2010). Not 
only presented in the soil, it can be found in almost all kinds of environments such as 
freshwater, air and marine environments (Mohseni et al., 2013). Experts estimate that 
the biological diversity is higher in some marine ecosystems such as the deep sea floor 
and coral reefs compared to that in the tropical rainforests. In the sea, actinomycetes also 
live in association with other microorganisms and they mediate the degradation and 
cycle the organic matter (Jensen et al., 2005a; Lam, 2006).  
 Actinomycetes are not only found in marine and terrestrial environment but also 
can be found in an extreme environment with very low temperature such as Antarctica in 
which 98% of the areas are covered with thick sheets of ice. Despite the extreme low 
temperature, rainfall and water is also scarce (Prabahar et al., 2004). Nedialkova and 
Naidenova (2004) successfully isolated a total of 40 actinomycetes strains from 
Antarctica soil sample while Fink and co-workers (1971) have isolated actinomycetes 
from genus Thermoactinomycetes from heating system of office buildings proving that 
some actinomycetes also live in thermophilic environment.  
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 Actinomycetes are rarely related to clinical practises and diseases but some of 
them may cause serious infection in human and animal (McNeil and Brown, 1994). 
Actinomycosis is one of the slow progressive infections caused by oral and 
gastrointestinal communal, Actinomycetes israelii. It is one of the chronic 
granulomatous disease (CGD) that commonly manifests as pulmonary, cervicofacial, or 
abdominal disease (Jahromi and Dootskam, 2011).  Actinomycetes form a compelling 
component of the commensal microflora of the gastrointestinal, oral and female genital 
tracts and they generally have low pathogenicity.  They may infect a body via breached 
mucosa, governing bacteremia and systemic infections in normal individuals and 
immuno-compromised patients (Clarridge and Zhang, 2002). Medication prescription of 
actinomycosis is usually easy in immunocompetent individuals by giving long-term and 
high-dose intravenous penicillin. It is more difficult in those with chronic granulomatous 
disease (CGD) patient because of delayed diagnosis and the increased risk of chronic 
invasive or incapacitates disease (Reichenbach et al., 2009). 
 As it may cause diseases, actinomycetes also may produce variety of drugs as 
they are also known as a major source of antibiotics. Actinomycetes have been 
discovered to be a supply reservoir of medicinal antibiotics and remarkably important to 
agricultural industries, pharmaceutical industries and scientists (Kumar et al., 2010). 
Majority of the   presently used antibiotics including streptomycin, erythromycin, 
gentamycin and rifamycin are all isolated from soil actinomycetes (Jeffrey, 2008). 
Streptomyces and Micromonospora are two major groups of soil actinomycetes that 
serve as important sources of antibiotics. It was discovered that genus 
Streptomyces alone contribute about 80% of the total medical antibiotic products; while 
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genus Micromonospora follows with less than one tenth as much as Streptomyces 
(Arifuzzaman et al., 2010). It has been proven by previous experimental analysis that the 
secondary metabolites isolated from soil actinomycetes are potential suppressor of 
numerous plant pathogens (Jeffrey, 2008). In agriculture field, Erwina amylovora; a 
bacterium that causes fireblight to apples and Agrobacterium tumefaciens; the causative 
pathogen of crown gall disease in plants has been proved to be inhibited by 
actinomycetes isolated from the farming soil (Oskay et al., 2004). There are 21 potential 
actinomycetes isolated by Valli and co-workers (2012) from marine environment that 
are reported to be the promising secondary metabolites producer against at least one 
tested organism. Studies have proven that actinomycetes isolated from the marine 
environment are capable of producing novel secondary metabolites and have adapted to 
life in the sea. Streptomyces can produce a variety of secondary active metabolites and 
medicinal antibiotic (Thenmozhi and Krishnan, 2011). Marine actinomycetes have 
different characteristics from those of terrestrial group because of marine environmental 
conditions that are extremely different from terrestrial. So, it gives a run down that they 
might produce different types of bioactive compounds (Imada et al., 2007).  
Actinomycetes that grow in the ocean are well adapted to the marine environment 
especially toleration to high Na
+
 and Cl
- 
ion concentration and high hydrostatic pressure. 
The adaptation made it an interesting organism to be studied as it may produce novel 
therapeutic agents (Subramani and Aalbersberg, 2012).  
 Nedialkova and Naidenova (2004) have successfully isolated a total of 40 
actinomycetes strains from Antarctica soil sample. All of the isolates were screened for 
antimicrobial bio-activity against seven Gram-positive and Gram-negative bacteria and 
